Nifty

:

25044.35

Sensex

:

82055.11

72.45 (0.29%)
158.32 (0.19%)

Login

Nifty
Sensex

:
:

25044.35
82055.11

72.45 (0.29%)
158.32 (0.19%)

Ajanta Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

69/99

BSE: 532331 | NSE: AJANTPHARM

Watchlist

NSE BSE

2564.20

24-Jun-2025

Open
High
Low
Previous Close

2580
2584.9
2555
2564.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

103086
264425051.5
3485
2160.15

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

32,037.46
34.81
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

31,863.81
1.09%
8.46

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

10.36
9.97
7.49

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.93
4.75
9.97

PAT CAGR (%)

10 Years
5 Years
3 Years

8.28
7.08
16.11

P:E (Median)

8 Years
5 Years
3 Years

25.76
27.86
35.32

P:BV (Average)

8 Years
5 Years
3 Years

5.78
6.32
7.04

EV:EBITDA (Average)

8 Years
5 Years
3 Years

18.09
19.70
22.03

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 64.82 73.56 82.87 97.31
P/E Ratio 39.56 34.86 30.94 26.35
Revenue 4162 4648 5228 5877
EBITDA 1172 1260 1460 1704
Net Income 816 920 1044 1238
ROA 17.5 19.1 21.1 21.3
P/B Ratio 9.52 8.45 7.07 5.99
ROE 23.47 25.02 24.88 24.58
FCFF 656 866 634 1070
FCFF Yield 2.06 2.73 1.99 3.37
Net Debt -426 -568 -435 -426
BVPS 269.46 303.44 362.48 428.09

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 1,013.94 926.07 9.49% 1,101.92 1,085.29 1.53% 1,128.91 945.18 19.44% 1,077.27 1,014.58 6.18%
Expenses 764.29 698.92 9.35% 765.59 758.11 0.99% 826.00 671.53 23.00% 761.44 737.68 3.22%
EBITDA 249.65 227.15 9.91% 336.33 327.18 2.80% 302.91 273.65 10.69% 315.83 276.90 14.06%
EBIDTM 24.62% 24.53% 30.52% 30.15% 26.83% 28.95% 29.32% 27.29%
Other Income 17.93 33.68 -46.76% 33.23 13.73 142.02% 40.34 52.16 -22.66% 28.37 31.46 -9.82%
Interest 0.67 1.42 -52.82% 2.48 2.36 5.08% 0.73 2.27 -67.84% 0.72 0.75 -4.00%
Depreciation 38.76 33.47 15.81% 34.93 33.41 4.55% 33.32 33.04 0.85% 32.92 32.24 2.11%
PBT 228.15 225.94 0.98% 332.15 305.14 8.85% 309.20 290.50 6.44% 310.56 275.37 12.78%
Tax 34.72 63.25 -45.11% 79.70 84.99 -6.22% 74.22 78.14 -5.02% 74.53 63.33 17.69%
PAT 193.43 162.69 18.89% 252.45 220.15 14.67% 234.98 212.36 10.65% 236.03 212.04 11.31%
PATM 19.08% 17.57% 22.91% 20.28% 20.81% 22.47% 21.91% 20.90%
EPS 15.49 13.03 18.88% 20.21 17.63 14.63% 18.81 17.00 10.65% 18.90 16.98 11.31%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 1,170.41 1,054.08 11.04% 1,146.13 1,105.15 3.71% 1,186.64 1,028.44 15.38% 1,144.92 1,021.04 12.13%
Expenses 873.26 775.76 12.57% 825.30 791.08 4.33% 875.47 737.78 18.66% 814.57 749.72 8.65%
EBITDA 297.15 278.32 6.77% 320.83 314.07 2.15% 311.17 290.66 7.06% 330.35 271.32 21.76%
EBIDTM 25.39% 26.40% 27.99% 28.42% 26.22% 28.26% 28.85% 26.57%
Other Income 18.11 35.50 -48.99% 30.44 13.59 123.99% 19.48 21.33 -8.67% 26.47 31.75 -16.63%
Interest 6.07 1.53 296.73% 7.91 2.49 217.67% 6.02 2.34 157.26% 0.73 0.85 -14.12%
Depreciation 39.78 34.25 16.15% 35.97 34.26 4.99% 34.39 33.71 2.02% 33.97 33.18 2.38%
PBT 269.41 278.04 -3.10% 307.39 290.91 5.66% 290.24 275.94 5.18% 322.12 269.04 19.73%
Tax 44.15 75.32 -41.38% 74.51 80.88 -7.88% 73.76 80.64 -8.53% 76.35 60.92 25.33%
PAT 225.26 202.72 11.12% 232.88 210.03 10.88% 216.48 195.30 10.84% 245.77 208.12 18.09%
PATM 19.25% 19.23% 20.32% 19.00% 18.24% 18.99% 21.47% 20.38%
EPS 17.97 16.04 12.03% 18.58 16.62 11.79% 17.27 15.46 11.71% 19.61 16.47 19.06%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales - 4,322.04 3,971.12 3,411.27 3,140.64 2,718.59 2,196.42 1,772.62 1,825.35 1,804.33 1,558.21 Net Sales Growth - 8.84% 16.41% 8.62% 15.52% 23.77% 23.91% -2.89% 1.16% 15.80% Cost Of Goods Sold - 833.45 892.98 824.32 679.10 600.59 546.67 304.80 311.26 348.99 318.31 Gross Profit - 3,488.59 3,078.14 2,586.95 2,461.54 2,118.00 1,649.75 1,467.82 1,514.09 1,455.34 1,239.90 GP Margin - 80.72% 77.51% 75.84% 78.38% 77.91% 75.11% 82.81% 82.95% 80.66% 79.57% Total Expenditure - 3,117.32 2,851.69 2,711.99 2,249.75 1,801.68 1,663.64 1,291.41 1,278.54 1,169.91 1,035.65 Power & Fuel Cost - 70.22 66.44 65.53 54.09 43.42 38.56 33.77 27.00 18.36 15.15 % Of Sales - 1.62% 1.67% 1.92% 1.72% 1.60% 1.76% 1.91% 1.48% 1.02% 0.97% Employee Cost - 1,010.90 834.16 720.41 585.87 498.11 437.82 389.37 342.89 269.78 235.03 % Of Sales - 23.39% 21.01% 21.12% 18.65% 18.32% 19.93% 21.97% 18.78% 14.95% 15.08% Manufacturing Exp. - 322.26 303.25 320.69 273.91 225.39 203.80 176.40 212.44 188.68 173.18 % Of Sales - 7.46% 7.64% 9.40% 8.72% 8.29% 9.28% 9.95% 11.64% 10.46% 11.11% General & Admin Exp. - 414.55 362.85 348.78 289.42 123.71 150.92 165.95 122.50 85.96 61.61 % Of Sales - 9.59% 9.14% 10.22% 9.22% 4.55% 6.87% 9.36% 6.71% 4.76% 3.95% Selling & Distn. Exp. - 377.46 313.06 354.87 316.58 248.70 225.44 178.54 173.75 161.51 164.06 % Of Sales - 8.73% 7.88% 10.40% 10.08% 9.15% 10.26% 10.07% 9.52% 8.95% 10.53% Miscellaneous Exp. - 88.48 78.95 77.39 50.78 61.76 60.43 42.58 88.70 96.63 164.06 % Of Sales - 2.05% 1.99% 2.27% 1.62% 2.27% 2.75% 2.40% 4.86% 5.36% 4.38% EBITDA - 1,204.72 1,119.43 699.28 890.89 916.91 532.78 481.21 546.81 634.42 522.56 EBITDA Margin - 27.87% 28.19% 20.50% 28.37% 33.73% 24.26% 27.15% 29.96% 35.16% 33.54% Other Income - 119.87 116.48 132.75 139.73 103.57 184.20 102.15 73.01 66.95 86.87 Interest - 4.60 6.80 5.23 9.12 6.90 9.10 0.41 0.24 1.24 4.19 Depreciation - 139.93 132.16 126.95 120.96 111.49 91.29 69.90 57.14 59.48 42.68 PBT - 1,180.06 1,096.95 699.85 900.54 902.09 616.59 513.05 562.44 640.65 562.56 Tax - 263.17 289.71 141.13 180.68 226.45 171.54 121.29 134.92 140.84 140.61 Tax Rate - 22.30% 26.41% 20.17% 20.06% 25.10% 28.00% 23.64% 23.99% 21.98% 24.99% PAT - 916.89 807.24 558.72 719.86 675.64 441.13 391.76 427.52 499.81 421.95 PAT before Minority Interest - 916.89 807.24 558.72 719.86 675.64 441.13 391.76 427.52 499.81 421.95 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 21.21% 20.33% 16.38% 22.92% 24.85% 20.08% 22.10% 23.42% 27.70% 27.08% PAT Growth - 13.58% 44.48% -22.38% 6.54% 53.16% 12.60% -8.36% -14.46% 18.45% EPS - 73.41 64.63 44.73 57.63 54.09 35.32 31.37 34.23 40.02 33.78

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales - 4,648.10 4,208.71 3,742.64 3,340.99 2,889.69 2,587.87 2,055.37 2,125.76 1,983.26 1,733.98 Net Sales Growth - 10.44% 12.45% 12.02% 15.62% 11.66% 25.91% -3.31% 7.19% 14.38% Cost Of Goods Sold - 892.19 880.13 869.31 677.73 514.99 537.75 295.72 317.35 322.58 317.33 Gross Profit - 3,755.91 3,328.58 2,873.33 2,663.26 2,374.70 2,050.12 1,759.65 1,808.41 1,660.68 1,416.65 GP Margin - 80.81% 79.09% 76.77% 79.71% 82.18% 79.22% 85.61% 85.07% 83.73% 81.70% Total Expenditure - 3,388.60 3,036.77 2,959.39 2,411.70 1,891.13 1,904.55 1,488.94 1,467.37 1,296.38 1,146.92 Power & Fuel Cost - 70.34 66.57 65.71 54.38 43.70 38.88 32.65 27.42 18.70 15.49 % Of Sales - 1.51% 1.58% 1.76% 1.63% 1.51% 1.50% 1.59% 1.29% 0.94% 0.89% Employee Cost - 1,089.69 900.34 785.14 645.78 548.25 485.59 430.71 376.47 295.42 256.64 % Of Sales - 23.44% 21.39% 20.98% 19.33% 18.97% 18.76% 20.96% 17.71% 14.90% 14.80% Manufacturing Exp. - 322.39 303.29 320.81 275.42 226.20 204.81 174.78 215.80 192.70 174.40 % Of Sales - 6.94% 7.21% 8.57% 8.24% 7.83% 7.91% 8.50% 10.15% 9.72% 10.06% General & Admin Exp. - 435.55 382.26 365.86 300.83 131.64 159.49 149.90 131.92 92.02 66.24 % Of Sales - 9.37% 9.08% 9.78% 9.00% 4.56% 6.16% 7.29% 6.21% 4.64% 3.82% Selling & Distn. Exp. - 482.41 417.54 463.94 400.29 374.73 413.70 320.99 306.30 270.92 245.92 % Of Sales - 10.38% 9.92% 12.40% 11.98% 12.97% 15.99% 15.62% 14.41% 13.66% 14.18% Miscellaneous Exp. - 96.03 86.64 88.62 57.27 51.62 64.33 84.19 92.11 104.04 245.92 % Of Sales - 2.07% 2.06% 2.37% 1.71% 1.79% 2.49% 4.10% 4.33% 5.25% 4.09% EBITDA - 1,259.50 1,171.94 783.25 929.29 998.56 683.32 566.43 658.39 686.88 587.06 EBITDA Margin - 27.10% 27.85% 20.93% 27.81% 34.56% 26.40% 27.56% 30.97% 34.63% 33.86% Other Income - 94.50 84.60 98.64 115.68 25.98 92.19 21.08 24.16 23.86 21.15 Interest - 20.73 7.21 5.84 10.20 8.27 11.91 1.16 0.41 1.36 4.89 Depreciation - 144.11 135.40 130.80 125.29 116.09 95.71 72.08 59.59 61.21 44.43 PBT - 1,189.16 1,113.93 745.25 909.48 900.18 667.89 514.27 622.55 648.17 558.89 Tax - 268.77 297.76 157.27 196.80 246.31 196.27 127.30 153.91 141.34 143.28 Tax Rate - 22.60% 26.73% 21.10% 21.64% 27.36% 29.56% 24.75% 24.72% 21.81% 25.64% PAT - 920.39 816.17 587.98 712.68 653.87 467.70 386.97 468.64 506.83 415.61 PAT before Minority Interest - 920.39 816.17 587.98 712.68 653.87 467.70 386.97 468.64 506.83 415.61 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 19.80% 19.39% 15.71% 21.33% 22.63% 18.07% 18.83% 22.05% 25.56% 23.97% PAT Growth - 12.77% 38.81% -17.50% 8.99% 39.81% 20.86% -17.43% -7.54% 21.95% EPS - 73.69 65.35 47.08 57.06 52.35 37.45 30.98 37.52 40.58 33.28

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 3,625.31 3,413.57 3,246.45 3,169.18 2,884.98 2,461.30 2,142.08 1,931.50 1,503.94 1,131.70 Share Capital 25.07 25.27 25.27 17.17 17.39 17.54 17.54 17.69 17.69 17.69 Total Reserves 3,595.06 3,382.65 3,220.84 3,151.71 2,867.04 2,443.29 2,123.44 1,912.18 1,486.25 1,114.01 Non-Current Liabilities 218.22 174.17 272.90 338.33 321.18 252.27 193.38 60.16 32.36 40.44 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.73 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.09 Long Term Provisions 80.27 39.54 146.55 216.04 208.12 155.01 134.15 13.16 4.89 2.59 Current Liabilities 710.72 629.19 907.84 469.70 706.28 614.30 427.47 300.19 212.24 241.55 Trade Payables 366.27 383.74 353.02 274.37 317.20 302.77 185.53 211.47 145.31 145.04 Other Current Liabilities 304.47 190.39 529.32 176.59 152.32 153.28 113.56 68.01 46.09 50.68 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 34.47 Short Term Provisions 39.98 55.06 25.50 18.74 236.76 158.25 128.38 20.71 20.84 11.36 Total Liabilities 4,554.25 4,216.93 4,427.19 3,977.21 3,912.44 3,327.87 2,762.93 2,291.85 1,748.54 1,413.69 Net Block 1,741.96 1,464.89 1,484.01 1,483.91 1,518.79 1,449.32 1,152.14 1,036.69 572.93 432.83 Gross Block 2,759.58 2,355.33 2,246.28 2,152.24 2,086.53 1,926.64 1,540.50 1,379.38 859.28 679.21 Accumulated Depreciation 1,017.62 890.44 762.27 668.33 567.74 477.32 388.36 342.69 286.35 246.38 Non Current Assets 1,978.19 1,775.77 1,876.00 1,920.20 1,886.04 1,773.43 1,593.76 1,196.84 973.47 715.27 Capital Work in Progress 176.27 256.45 209.47 152.86 108.19 131.06 261.29 61.33 254.22 198.91 Non Current Investment 43.13 37.09 42.99 42.99 17.89 18.63 28.14 18.26 17.26 17.25 Long Term Loans & Adv. 13.12 12.97 134.68 226.15 230.52 163.96 139.91 66.38 34.93 21.12 Other Non Current Assets 3.71 4.37 4.85 5.88 10.65 10.46 12.28 14.18 9.09 4.27 Current Assets 2,567.21 2,432.82 2,543.27 2,057.01 2,026.40 1,554.44 1,169.17 1,095.01 775.07 698.42 Current Investments 438.71 330.05 510.27 121.86 138.99 67.14 64.74 182.38 181.56 76.78 Inventories 739.29 677.79 683.77 635.11 634.22 436.19 414.26 317.37 179.28 189.78 Sundry Debtors 1,225.81 1,207.67 977.63 1,043.62 782.30 734.24 423.38 432.19 336.00 350.48 Cash & Bank 49.72 63.06 269.92 145.25 151.98 87.85 35.87 38.67 22.84 21.44 Other Current Assets 113.68 44.34 18.56 29.78 318.91 229.02 230.92 124.40 55.39 59.94 Short Term Loans & Adv. 82.29 109.91 83.12 81.39 219.81 163.63 137.20 12.71 48.26 53.75 Net Current Assets 1,856.49 1,803.63 1,635.43 1,587.31 1,320.12 940.14 741.70 794.82 562.83 456.87 Total Assets 4,545.40 4,208.59 4,419.27 3,977.21 3,912.44 3,327.87 2,762.93 2,291.85 1,748.54 1,413.69

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 3,790.29 3,567.36 3,387.99 3,264.34 2,995.63 2,598.87 2,245.21 2,041.37 1,567.69 1,190.86 Share Capital 25.07 25.27 25.27 17.17 17.39 17.54 17.54 17.69 17.69 17.69 Total Reserves 3,760.04 3,536.44 3,362.38 3,246.87 2,977.70 2,580.86 2,226.57 2,022.05 1,550.00 1,173.17 Non-Current Liabilities 42.13 40.82 177.38 285.02 274.55 227.61 162.23 38.56 8.90 28.63 Secured Loans 0.00 0.00 1.25 1.64 1.60 0.74 0.66 1.01 1.04 5.79 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.08 Long Term Provisions 80.27 39.54 146.55 216.04 208.12 155.01 134.15 13.16 4.88 2.59 Current Liabilities 996.10 895.25 1,139.28 647.39 838.82 745.53 498.35 346.05 246.66 259.89 Trade Payables 454.20 463.20 422.77 327.17 373.86 362.34 225.18 249.63 178.18 145.57 Other Current Liabilities 478.02 369.52 669.42 301.47 214.14 180.12 111.45 63.95 46.33 56.72 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 42.85 33.34 0.00 0.00 46.25 Short Term Provisions 63.88 62.53 47.09 18.75 250.82 160.22 128.38 32.47 22.15 11.35 Total Liabilities 4,828.52 4,503.43 4,704.65 4,196.75 4,109.00 3,572.01 2,905.79 2,425.98 1,823.25 1,479.38 Net Block 1,762.02 1,479.19 1,496.44 1,503.58 1,541.11 1,472.14 1,168.35 1,052.66 589.17 450.74 Gross Block 2,801.05 2,389.41 2,282.82 2,206.86 2,140.80 1,976.15 1,578.96 1,417.23 894.94 715.73 Accumulated Depreciation 1,039.03 910.22 786.38 703.28 599.69 504.01 410.61 364.57 305.77 264.99 Non Current Assets 1,985.49 1,773.02 1,870.65 1,932.29 1,891.22 1,790.94 1,605.27 1,202.36 972.65 716.11 Capital Work in Progress 176.27 256.45 209.47 152.86 108.19 131.86 261.61 61.33 254.22 198.91 Non Current Investment 25.24 18.58 25.10 25.10 0.00 12.28 22.87 7.58 0.00 0.00 Long Term Loans & Adv. 18.25 14.43 134.79 236.46 230.74 164.20 148.36 76.79 41.88 21.29 Other Non Current Assets 3.71 4.37 4.85 5.88 11.18 10.46 4.08 4.00 2.34 4.28 Current Assets 2,829.70 2,722.07 2,825.18 2,264.46 2,217.78 1,781.07 1,300.52 1,223.62 850.60 763.27 Current Investments 438.71 330.05 510.27 121.86 175.67 67.14 64.74 182.38 181.56 76.78 Inventories 903.85 828.36 815.63 791.07 766.47 495.68 435.71 350.63 211.02 204.58 Sundry Debtors 1,182.74 1,246.84 1,056.90 1,019.81 738.43 775.30 459.48 459.79 323.15 372.35 Cash & Bank 176.24 130.77 330.90 211.79 209.61 205.25 100.51 93.09 69.95 43.37 Other Current Assets 128.16 53.76 22.09 34.79 327.60 237.70 240.08 137.73 64.92 66.19 Short Term Loans & Adv. 89.36 132.29 89.39 85.14 223.45 168.68 143.45 23.11 56.29 59.39 Net Current Assets 1,833.60 1,826.82 1,685.90 1,617.07 1,378.96 1,035.54 802.17 877.57 603.94 503.38 Total Assets 4,815.19 4,495.09 4,695.83 4,196.75 4,109.00 3,572.01 2,905.79 2,425.98 1,823.25 1,479.38

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 1,053.80 735.35 736.29 542.34 466.99 300.88 311.82 219.17 536.90 276.67 PBT 1,180.06 1,096.95 699.85 900.54 902.09 612.67 513.05 562.44 640.65 562.56 Adjustment 69.38 49.31 79.34 55.58 37.07 -36.60 -11.56 0.21 40.16 -21.87 Changes in Working Capital 86.19 -158.63 82.66 -220.31 -274.26 -136.66 -86.64 -221.02 -13.32 -111.94 Cash after chg. in Working capital 1,335.63 987.63 861.85 735.81 664.90 439.41 414.85 341.63 667.49 428.75 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -281.83 -252.28 -125.56 -193.47 -197.91 -138.53 -103.03 -122.46 -130.59 -152.08 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -349.60 105.02 -501.31 -66.04 -162.68 -115.91 -136.88 -201.13 -339.66 -139.39 Net Fixed Assets -324.07 -156.03 -150.65 -110.38 -137.02 -255.91 -361.08 -327.21 -235.38 -197.00 Net Investments -114.70 186.12 -388.41 -7.97 -71.11 7.11 107.76 -1.82 -104.79 -17.41 Others 89.17 74.93 37.75 52.31 45.45 132.89 116.44 127.90 0.51 75.02 Cash from Financing Activity -715.71 -1,047.70 -105.12 -457.30 -268.90 -134.00 -180.89 -0.54 -198.02 -128.38 Net Cash Inflow / Outflow -11.51 -207.33 129.86 19.00 35.41 50.97 -5.95 17.50 -0.78 8.90 Opening Cash & Equivalents 61.78 268.85 139.83 119.88 84.95 30.52 36.22 18.72 19.49 10.59 Closing Cash & Equivalent 50.27 61.52 269.69 138.88 120.36 81.49 30.27 36.22 18.71 19.49

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 1,157.23 785.07 792.11 561.71 576.31 456.77 374.51 281.12 609.29 326.14 PBT 1,189.16 1,113.93 745.25 909.48 900.18 663.97 514.27 622.56 648.17 558.90 Adjustment 112.11 83.03 131.30 91.75 115.27 70.79 61.93 52.48 86.33 53.07 Changes in Working Capital 178.93 -99.76 66.85 -200.39 -208.75 -123.16 -83.46 -254.32 25.88 -124.34 Cash after chg. in Working capital 1,480.20 1,097.20 943.40 800.84 806.70 611.60 492.74 420.72 760.38 487.63 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -322.97 -312.13 -151.29 -239.13 -230.39 -154.83 -118.23 -139.60 -151.09 -161.49 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -376.52 65.39 -559.60 -74.10 -282.38 -224.40 -222.78 -256.11 -383.12 -209.07 Net Fixed Assets -324.07 -156.03 -150.65 -110.38 -137.02 -255.91 -361.08 -327.21 -235.38 -197.00 Net Investments -114.70 186.12 -388.41 -7.97 -71.11 7.11 107.76 -1.82 -104.79 -17.41 Others 62.25 35.30 -20.54 44.25 -74.25 24.40 30.54 72.92 -42.95 5.34 Cash from Financing Activity -733.41 -1,051.06 -108.20 -459.71 -318.29 -128.63 -147.46 -0.20 -201.77 -117.32 Net Cash Inflow / Outflow 47.30 -200.60 124.31 27.90 -24.36 103.74 4.27 24.81 24.40 -0.25 Opening Cash & Equivalents 129.49 329.83 206.36 177.51 202.35 95.16 90.64 65.83 41.42 41.67 Closing Cash & Equivalent 176.79 129.23 330.67 205.41 177.99 198.90 94.91 90.64 65.82 41.42

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 289.84 270.68 257.83 247.37 222.30 282.03 245.37 219.29 170.89 128.59 ROA 20.91% 18.68% 13.30% 18.25% 18.66% 14.49% 15.50% 21.16% 31.61% 33.76% ROE 26.09% 24.26% 17.42% 23.78% 25.28% 19.17% 19.25% 24.90% 37.93% 44.01% ROCE 33.66% 33.15% 21.98% 30.05% 34.00% 27.01% 25.21% 32.76% 47.50% 55.13% Fixed Asset Turnover 1.75 1.78 1.59 1.50 1.37 1.27 1.21 1.64 2.37 2.64 Receivable days 99.10 97.40 105.33 104.55 100.41 96.19 88.09 76.59 68.73 68.58 Inventory Days 57.71 60.68 68.73 72.68 70.87 70.66 75.32 49.52 36.95 39.76 Payable days 164.23 150.57 138.90 158.98 188.39 57.84 60.10 55.05 50.18 46.47 Cash Conversion Cycle -7.42 7.51 35.15 18.26 -17.11 109.01 103.31 71.06 55.51 61.87 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 Interest Cover 257.53 162.32 134.81 99.74 131.74 68.33 1252.34 2344.50 517.65 135.26

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 303.04 282.89 269.07 254.80 230.83 297.80 257.19 231.78 178.14 135.31 ROA 19.72% 17.73% 13.21% 17.16% 17.03% 14.44% 14.52% 22.06% 30.69% 31.66% ROE 25.06% 23.49% 17.68% 22.77% 23.38% 19.32% 18.07% 25.98% 36.75% 40.92% ROCE 32.87% 32.22% 22.57% 29.37% 32.20% 27.44% 23.84% 34.49% 45.74% 51.61% Fixed Asset Turnover 3.43 3.42 3.19 1.56 1.43 1.46 1.37 1.84 2.49 2.76 Receivable days 49.80 52.69 52.87 94.50 93.66 87.08 81.62 67.06 63.41 65.84 Inventory Days 35.51 37.60 40.91 83.71 78.09 65.68 69.82 48.10 37.89 37.93 Payable days 187.66 183.71 157.44 188.77 260.89 59.55 63.24 57.26 50.30 41.91 Cash Conversion Cycle -102.34 -93.41 -63.66 -10.56 -89.14 93.21 88.21 57.90 51.01 61.86 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.02 0.02 0.00 0.00 0.07 Interest Cover 58.36 155.50 128.61 90.16 109.85 56.75 444.34 1519.41 477.60 115.29

Top Investors:

uti-flexi cap fund

nippon life india trustee ltd-a/c nippon india small cap fund

kotak small cap fund

canara robeco mutual fund a/c canara robeco emerging equities

tata aia life insurance co ltd-whole life mid cap equity fund-ulif 009 04/01/07 wle 110

hdfc large and mid cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Ajanta Pharma to expand manufacturing capacity
21st Mar 2025, 14:09 PM

The investments required for the capacity addition is Rs 92 crore
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback